Gateways to clinical trials -: January/February 2003

被引：0

作者：

Bayés, M ^{[1
]}

Rabasseda, X ^{[1
]}

Prous, JR ^{[1
]}

机构：

[1] Prous Sci SA, Barcelona 08080, Spain

来源：

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2003年 / 25卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity, the drug discovery and development portal, http://integrity.prous.com. This issue focuses on the following selection of drugs: 81C6; Adefovir dipivoxil, Agalsidase alfa, AGM-1470, albumin interferon alfa, alefacept, alosetron hydrochloride, anakinra, anti-CTLA-4 Mab, aprepitant, aripiprazole, atazanavir,BAY-43-9006, BBR-3438, beta-L-Fd4C, bimatoprost, bortezomib, bosentanBR96-doxorubicin; Caspofungin acetate, ciclesonide, cilengitide, cilomilast, COL-1621, COL-3, CpG-7909, cyclosporine; DCVax-Brain, dexmethylphenidate hydrochloride, dexosome vaccine (melanoma), donepezil hydrochloride, drotrecogin alfa (activated), DTI-015, [99Tc]-DTPA-mannosyldextran, duloxetine hydrochloride; Emivirine, emtricitabine, entecavir, epothilone B, estradiol-MNP, etonogestrel, etonogestrel/ethinylestradiol, etoricoxib; Febuxostat, fondaparinux sodium, fosamprenavir calcium; Gefitinib, GVS-111; Heparinase 1, HspE7, human alpha-glucosidase, human insulin; Imatinib mesylate, INGN-241, interferon alfa BID hybrid, interferon alfa Biphasix, ISIS-14803; Lanicemine hydrochloride, 131I-lipiodol, liposome-encapsulated mitoxantrone, lixivaptan, lumiracoxib, lupus-AHP, LY-466700; Marimastat, MEN-10755, micafungin sodium; Nitronaproxen, NSC-683864 Omalizumab, oral insulin; Palonosetron hydrochloride, peginterferon alfa-2a, pimecrolimus, pralnacasan, pramlintide acetate, pregabalin, pyrazoloacridine; R-165335, ranolazine, risperidone, RPR-109881;, RSD-1235, Satraplatin, seocalcitol, sertindole, SMART anti-interferon gamma antibody, sulfasalazine; T-138067, TAK-013, tegaserod maleate, telithromycin, tenofovir disoproxil fumarate, teriparatide, tiotropium bromide, tipifarnib, TP-38; Valdecoxib, vatalanib succinate, voriconazole; ZD-9331. (C) 2003 Prous Science. All rights reserved.

引用

下载

页码：53 / 76

页数：24

共 50 条

[41] The 2003 Mozart week in Salzburg, January 24 to February 2
Cosse, P
OSTERREICHISCHE MUSIKZEITSCHRIFT, 2003, 58 (3-4): : 60 - 62
[42] Gateways to clinical trials -: July/August 2005
Bayés, M
Rabasseda, X
Prous, JR
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2005, 27 (06): : 411 - 461
[43] The latest video and DVD releases (January-February 2003)
Smith, G
FILM COMMENT, 2003, 39 (01) : 77 - +
[44] Critics choice (Film ratings for January-February 2003)
Dargis, M
Ebert, R
Hoberman, J
Kehr, D
Morris, W
Rosenbaum, J
Smith, G
White, A
FILM COMMENT, 2003, 39 (01) : 19 - 19
[45] New resources for evidence-based practice, January/February 2003
Sakala, C
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2003, 32 (01): : 83 - 85
[46] Phase III Clinical Trials in Oncology - 20-21 January 2003, London, UK
Buyse, M
IDRUGS, 2003, 6 (03) : 187 - 190
[47] Clinical Trials in Neuroprotection -: 23-25 January 2003, Key Biscayne, FL, USA
Pitkänen, A
IDRUGS, 2003, 6 (03) : 200 - 202
[48] Spanish and EU Law published at BOE and DOCE from January to February 2003
de Rojas, DBS
AFINIDAD, 2003, 60 (504) : 134 - 135
[49] Editorial for January/February Issue of AACE Clinical Case Reports
Jasim, Sina
AACE CLINICAL CASE REPORTS, 2023, 9 (01): : 37 - 37
[50] Editorial for January/February Issue of AACE Clinical Case Reports
Jasim, Sina
AACE CLINICAL CASE REPORTS, 2022, 8 (01): : 1 - 1

← 1 2 3 4 5 →